The available evidence indicates that SOD and other antioxidant enzymes are decreased in pre-clinical models of AKI [46], and genetic impairment of SOD increases sensitivity to AKI in ischemia [47] and chronic hypoxia [48]. This evidence concerns the gene SOD1 and acute kidney injury.